BRS 305 sorghum bran (SB) has a high content of dietary fiber and phenolic compounds, which may positively modulate central satiety pathways and obesity management. This study aimed to investigate the effects of BRS 305 sorghum bran on satiety pathways in the ileum-brain axis in obese mice. Twenty-four C57BL/6 mice were randomly allocated in standard control diet (AIN) (n=8) and high-fat diet (HFD) (n=16) groups for 8 weeks to induce obesity. Subsequently, they were redistributed into AIN, HFD, and HFD+SB groups (n=8/group) for an additional 8-week intervention. Murinometric data, food intake, ileum histology, gene expression of satiety-related markers in ileum (GLP-1 and PYY) and brain (MC4R and LepR) (RT-qPCR), brain leptin concentrations (ELISA), and in silico molecular docking were assessed. The HFD+SB group improved ileal morphology, with increased villus height, goblet cell area, and number of goblet cells/villi relative to HFD. Further, the HFD+SB group showed higher GLP-1, PYY, MC4R, and LepR gene expression, but did not change brain leptin concentrations compared to HFD group. Docking analyses demonstrated that SB phenolic compounds, such as apigeninidin, luteolinidin, and sinapic acid, promoted the interaction between leptin and its receptor, supporting the molecular basis for increased satiety. These findings supported the reduction of food intake and final body weight in animals fed SB. Thus, BRS 305 sorghum bran improves gut morphology and modulates satiety pathways in the ileum-brain axis in obese mice induced by a high-fat diet, reinforcing its potential as a functional dietary component for obesity management.